X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/prostate-cancer-adc-acquired-fortis-breaks-fibrogens-clinical-losing-streak
https://www.globenewswire.com/news-release/2024/04/02/2856521/33525/en/FibroGen-Announces-Topline-Results-from-Phase-1-Monotherapy-Study-of-FG-3246-in-Patients-with-Metastatic-Castration-Resistant-Prostate-Cancer.html
https://www.globenewswire.com/news-release/2024/03/26/2852209/33525/en/FibroGen-to-Present-at-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/03/11/2843607/33525/en/FibroGen-Appoints-Deyaa-Adib-M-D-as-Chief-Medical-Officer.html
https://www.globenewswire.com//news-release/2024/02/26/2835501/33525/en/FibroGen-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/26/2835490/33525/en/FibroGen-Regains-All-Rights-to-Roxadustat-from-AstraZeneca-in-the-United-States-and-Other-AstraZeneca-Territories-Except-China-and-South-Korea.html
https://www.globenewswire.com//news-release/2024/02/20/2831663/33525/en/FibroGen-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/05/2823393/33525/en/FibroGen-To-Host-Part-I-of-Virtual-KOL-Investor-Event-Series-to-Review-Pamrevlumab-Clinical-Program-in-Pancreatic-Cancer-on-February-13-2024.html
https://www.globenewswire.com//news-release/2024/01/25/2816553/33525/en/FibroGen-Announces-Completion-of-the-Pamrevlumab-Arm-in-Precision-Promise-Pancreatic-Cancer-Action-Network-s-Phase-2-3-Adaptive-Platform-Trial-for-Metastatic-Pancreatic-Cancer.html
https://www.globenewswire.com//news-release/2023/12/09/2793446/33525/en/FibroGen-Presents-Data-from-Phase-3-MATTERHORN-Trial-of-Roxadustat-in-Patients-with-Anemia-of-Lower-Risk-Transfusion-Dependent-Myelodysplastic-Syndromes-at-American-Society-of-Hema.html
Market Place
Share 
